13F-HR filed by EMORY UNIVERSITY
EMORY UNIVERSITY filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 19 holding rows worth $50,716,000.
- Accession
- 0001377635-19-000005
- Filer
- CIK 1377635
- Filed
- 2019-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 19 entries on the cover page, a total value of $50,716,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $50,716,000 with VALUE read as thousands by filing date, 13F file number 028-16101. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 084670108 | CL A | 100 | $31,183,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 67,753 | $2,437,000 | thousands by filing date | |
| SYNTHORX INC COM | 87167A103 | Stock | 145,150 | $2,362,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 78,212 | $1,606,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 71,856 | $1,551,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 59,690 | $1,412,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 479,902 | $1,375,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 81,176 | $1,295,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 108,692 | $1,291,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 24,890 | $997,000 | thousands by filing date | |
| ARCOSA INC COM | 039653100 | Stock | 27,923 | $955,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 49,974 | $925,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 77,180 | $895,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 146,475 | $762,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 9,506 | $645,000 | thousands by filing date | |
| SUMMIT MIDSTREAM PARTNERS LP | 866142102 | COM UNIT LTD | 70,456 | $342,000 | thousands by filing date | |
| COCRYSTAL PHARMA INC | 19188J300 | CMN | 152,916 | $312,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 942 | $280,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 36,818 | $91,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001377635-19-000005 | this filing | 2019-11-14 | acceptance time not in the bulk data set |